Skip to main content

CRISPR Creates Knockout Libraries

Two research groups have developed a database of human gene knockouts generated from the new genome editing technology.  

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKIMEDIA, NISSIM BENVENISTY CRISPR technology is an approach to genome editing that has skyrocketed to stardom because of its speed, ease of use, efficiency, and ever-expanding applications. Now, two groups seized upon CRISPR (which stands for Clustered Regularly Interspaced Short Palindromic Repeats) to build knockout libraries of human genes. “With this work, it is now possible to conduct systematic genetic screens in mammalian cells,” David Sabatini, an author of one of the studies and a member of the Whitehead Institute, said in a statement.

Bacteria and archaea use clustered regularly interspaced short palindromic repeats use in immune responses, but researchers have exploited the genetic components to rewrite or disrupt specific sites in the genomes of myriad organisms, including human cells. In both of the new studies, published last week in Science, the teams used their CRISPR-built libraries to screen for human genes involved in resistance to cancer drugs.

The study authors say CRISPR offers major advantages over RNAi, the common approach to conducting mutant screens in mammalian cells. “The CRISPR-Cas9 screening method distinguishes itself from RNAi by producing knockouts instead of knockdowns and it will be cleaner for many phenotypes to see the complete knockout,” David Root, director of the Broad Institute's Genetic Perturbation Platform and an author of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo